Enhanced follow-up for patients with Trifecta aortic replacement valves

BHVS is delighted to have collaborated with the British Cardiovascular Society (BCS) and the Society for Cardiothoracic Surgery (SCTS) to produce a Joint Statement regarding enhanced follow-up for patients with a Trifecta aortic valve replacement, following an advisory safety warning issued in summer 2020 by the Medicines and Health Regulatory Authority (MHRA).